WO2006138238A3
(en )
2007-07-19
Methods of protecting against apoptosis using lipopeptides
MX2009007075A
(en )
2009-12-14
Methods of use for cyclopamine analogs.
MX2018014998A
(en )
2021-12-08
Use of toll-like receptor agonist for treating cancer.
JO2788B1
(en )
2014-03-15
Amidophenoxyindazoles useful as inhibitors of c-met
EP2659353A4
(en )
2017-04-12
Techniques for protecting against denial of service attacks near the source
MX360301B
(en )
2018-10-29
Boron-containing small molecules as anti-inflammatory agents.
MY181898A
(en )
2021-01-12
Heterocyclic compounds and uses thereof
SG179085A1
(en )
2012-04-27
Pi3 kinase inhibitors and uses thereof
MA33803B1
(en )
2012-12-03
BENZODIAZEPINE BROMODOMAINE INHIBITOR
MY165728A
(en )
2018-04-20
Selective glycosidase inhibitors and uses thereof
IN2012DN00471A
(en )
2015-06-05
MX338489B
(en )
2016-04-18
Hydantoin derivatives useful as kv3 inhibitors.
MX2009006627A
(en )
2009-08-12
Quinazolines for pdk1 inhibition.
MY153766A
(en )
2015-03-13
Derivatised proline containing peptide organic compounds as protease inhibitors
MX2012004780A
(en )
2012-08-23
Akt inhibitors.
MX2013007268A
(en )
2013-12-06
Bicyclic pkm2 activators.
EP2557919A4
(en )
2013-12-25
Stabilized statin formulations
SG158091A1
(en )
2010-01-29
Imidazoazepinone compounds
WO2005056042A3
(en )
2005-11-10
Methods of protecting against radiation using flagellin
AR072425A1
(en )
2010-08-25
USE OF NIFURTIMOX FOR THE TREATMENT OF GIARDIASIS
MY153572A
(en )
2015-02-27
Methods or protecting against apoptosis using lipopeptides
UY33542A
(en )
2012-02-29
USE OF TERIFLUNOMIDE TO TREAT MULTIPLE SCLEROSIS
MY148435A
(en )
2013-04-30
Methods of protecting against radiation using flagellin
AU335301S
(en )
2011-03-02
Mattock head
UA35660U
(en )
2008-09-25
Use of antihomotoxic preparations as cytoprotectors